Company intelligence / Profile preview
Vopec Pharmaceuticals
- Ownership
- Private
- Development stage
- Phase 1
Overview
Vopec Pharmaceuticals has demonstrated Phase IV clinical efficacy with Amrta Karuna (significant reduction in viral disease burden in COVID-19 trial group), out-licensed a psoriasis treatment after a successful clinical trial, and is engaged in early-stage/ preclinical development of oncology candidates and antivirals.
- Therapeutic areas
- DermatologyInfectious DiseasesOncology
- Modalities
- Small moleculeLarge moleculeHerbal extractNutraceutical
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Vopec Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vopec Pharmaceuticals.